Cardinal Health Stock Forecast

Stock Price Forecast

According to 17 analysts polled by S&P Global, Cardinal Health stock has a consensus rating of "Buy" and an average price target of $273.47. The average 1-year stock price forecast is 8.91% higher than the current stock price, while the lowest is $235 (-6.41%) and the highest is $295 (+17.49%).

Price Target: $273.47 (+8.91%)

Analyst Consensus: Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$235	$273.47	$276	$295
Change	-6.41%	+8.91%	+9.92%	+17.49%

Analyst Ratings

The average analyst rating for Cardinal Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart

Rating	May '26	Jun '26	Jul '26	Aug '26	Sep '26	Oct '26
Strong Buy	12	12	12	12	11	11
Buy	2	2	2	3	3	3
Hold	3	3	3	3	3	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	17	17	17	18	17	17

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Glen Santangelo Barclays	Barclays	Buy Maintains $275	Buy	Maintains	$275	+9.52%	Oct 27, 2026
Steven Valiquette Mizuho Securities	Mizuho Securities	Buy Maintains $250 → $280	Buy	Maintains	$250 → $280	+11.51%	Oct 20, 2026
Kevin Caliendo UBS	UBS	Buy Maintains $280 → $295	Buy	Maintains	$280 → $295	+17.49%	Oct 16, 2026
Ryan Halsted RBC Capital	RBC Capital	Buy Maintains $276	Buy	Maintains	$276	+9.92%	Oct 13, 2026
Stephen Baxter Wells Fargo	Wells Fargo	Buy Maintains $277	Buy	Maintains	$277	+10.32%	Sep 10, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

265.77B

from 254.25B

4.53%

from 254.25B

Revenue Next Year

281.85B

from 265.77B

6.05%

from 265.77B

EPS This Year

12.56

from 10.95

14.75%

from 10.95

EPS Next Year

14.06

from 12.56

11.89%

from 12.56

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Jun 30, 2022	Jun 30, 2023	Jun 30, 2024	Jun 30, 2025	Jun 30, 2026	Jun 30, 2027
Revenue	181.33B	204.98B	226.83B	222.58B	254.25B	265.77B
Revenue Growth	11.61%	13.04%	10.66%	-1.87%	14.23%	4.53%
Gross Profit	6.48B	6.87B	7.41B	8.17B	9.77B	10.26B
Gross Margin	3.58%	3.35%	3.27%	3.67%	3.84%	3.86%
Operating Income	1.65B	1.79B	2.13B	2.49B	3.29B	3.91B
Net Income	-938.00M	330.00M	852.00M	1.56B	1.71B	2.32B
EPS	-	-	-	-	10.95	12.56
EPS Growth	-	-	-	-	32.89%	14.75%
Forward PE	9.77	14.77	13.43	18.60	20.44	19.98
Dividend / Share	1.97	1.99	2.01	2.03	2.05	2.10
Dividend Growth	1.45%	1.00%	0.99%	1.00%	1.01%	2.37%
Free Cash Flow	-	-	-	-	4.53B	3.44B
No. Analysts	-	-	-	-	-	15

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2027	2028	2029
High	268.3B
Avg	265.8B
Low	263.5B

Revenue Growth

Chart

Revenue Growth	2027	2028	2029
High	5.5%
Avg	4.5%
Low	3.7%

EPS Forecast

Chart

EPS	2027	2028	2029
High	12.74
Avg	12.56
Low	12.51

EPS Growth

Chart

EPS Growth	2027	2028	2029
High	16.3%
Avg	14.7%
Low	14.2%